Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Human Papillomavirus Vaccines
Reports by M. Lidqvist and co-researchers describe recent advances in human papillomavirus vaccines
October 7th, 2008
New research, 'Phage display for site-specific immunization and characterization of high-risk human papillomavirus specific E7 monoclonal antibodies,' is the subject of a report. According to recent research from Gothenburg, Sweden, "The paper describes a method to use filamentous phage to display specific regions of proteins for immunization in order to direct the immune response towards a pre-defined region of the protein. The method called site-specific immunization (SSI) was evaluated using the E7 protein of oncogenic (high-risk) human papillomavirus (HPV) type 16 as a model system." "This protein consists of sequence blocks also present in other viral and cellular...
Source: Cancer Weekly (2008-10-07)
|
